Bausch Health Companies | VRX - Market Capitalization


Bausch Health Companies reported $2.8B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amgen USD 189.89B 13.64B Mar/2026
ANI Pharmaceuticals USD 1.75B 24M Mar/2026
Aurora Cannabis CAD 327.21M 142.93M Dec/2025
Biogen USD 26.9B 1.09B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Canopy Growth CAD 656.46M 124.89M Dec/2025
Corcept Therapeutics USD 4.32B 654M Mar/2026
Danaher USD 128.46B 33.24B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Gilead Sciences USD 172.99B 20.71B Mar/2026
Nektar Therapeutics USD 11.91B 11.05B Jun/2026
Novo Nordisk A/S DKK 1.03T 421.31B Mar/2026
Pacira USD 915M 149M Mar/2026
Perrigo USD 1.31B 604M Mar/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.8B 161M Mar/2026
Supernus Pharmaceuticals USD 2.98B 126M Mar/2026
Vertex Pharmaceuticals USD 113.58B 1.44B Mar/2026
Zoetis USD 49.71B 5.74B Mar/2026